Zusammenfassung
Bei einem 4-jährigen Mädchen konnte die Diagnose Osteogenesis imperfecta Typ I anhand folgender klinischer Merkmale gestellt werden: 4 Frakturen jeweils nach Bagatelltraumata, intensiv blaue Skleren beidseits, Zahnschmelzanomalien, Makrozephalie mit vorgewölbter Stirn. Die Diagnose wurde molekulargenetisch bestätigt. Dabei fand sich eine heterozygote Punkt-mutation Arg420Stop im COL1A1-Gen, welche in der Literatur bisher nicht beschrieben ist.
Abstract
In a 4 year old girl the diagnosis osteogenesis imperfecta type I was suspected by following clinical criteria: four fractures after small trauma, intensive blue sclera, anomalies of dental enamel, macrocephalie with frontal bassing. Clinical diagnosis could be verified by moleculargenetic analysis, a newly recognized heterozygous point mutation (Arg420Stop) in the COL1A1-gene was found.
Schlüsselwörter
Osteogenesis imperfecta - COL1A1-Gen - Knochenfragilität
Key words
Osteogenesis imperfecta - COL1A1-gene - bone fragility
Literatur
-
1
Allgrove J.
Use of Bisphosphonates in Children and Adolescents.
J Pediatr Endocrinol Metabol.
2002;
15
921-928
-
2
Antoniazzi F, Mottes M, Fraschini P, Brunelli P C, Tato L.
Osteogenesis imperfecta: practical treatment guidelines.
Paediatr Drugs.
2002;
2
(6)
465-488
-
3
Aström E, Söderhäll S.
Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta.
Arch Dis Child.
2002;
86
356-364
-
4
Chevrel G, Meunier P J.
Osteogenesis imperfecta: lifelong management is imperative and feasible.
Joint Bone Spine.
2001;
68
(2)
125-129
-
5
Forlino A, Marini J C.
Osteogenesis Imperfecta: Prospects for Molecular Therapeutics.
Mol Gen Metabol.
2000;
71
225-232
-
6
Glorieux F H, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, Lalic L, Glorieux D F, Fassier F, Bishop N J.
Type V osteogenesis imperfecta: a new form of brittle bone disease.
J Bone Miner Res.
2000;
15
(9)
1650-1658
-
7
Glorieux F H, Ward L M, Rauch F, Lalic L, Roughley P J, Travers R.
Osteogenesis imperfecty type VI: a form of brittle bone disease with a mineralization defect.
J Bone Miner Res.
2002;
17
(1)
30-38
-
8
Glorieux F H.
Bisphosphonate Therapy for Severe Osteogenesis Imperfecta.
J Ped Endocrinol Metabol.
2000;
13
989-992
-
9
Landsmeer-Beker E A, Massa G G, Maaswinkel-Mooy P D, van de Kamp J JP, Papapoulos S E.
Treatment of osteogenesis imperfecta with the bisphosphonates olpadronate (dimethylaminohydroxypropylidene bisphosphonate).
Eur J Pediatr.
1997;
156
792-794
-
10
Moriwake T, Seino Y.
Recent progress in diagnosis and treatment of osteogenesis imperfecta.
Acta Paediatr Jpn.
1997;
39
(4)
521-527
-
11 Revell P A. Bones and Joints. In: Sir Colin Berry (ed) Pediatric Pathology. 3rd edition. Berlin, Heidelberg, New York; Springer 1996: 533-535
-
12
Trummer T, Brenner R, Just W, Vogel W, Kennerknecht I.
Recurrent mutations in the COL1A2gene in patients with osteogenesis imperfecta.
Clinical Genetics.
2001;
59
(5)
338-343
PD Dr. med. Heinrich Schmidt
Dr. von Haunersches Kinderspital
Lindwurmstraße 4
80337 München
Phone: + 49-89-5160-2811
Fax: + 49-89-5160-4192
Email: Heinrich.Schmidt@kk-i.med.uni-muenchen.de
